Background: Sleep disturbance is a common complaint of patients with cancer and is well established in both pain conditions and post-traumatic stress disorder (PTSD). An estimated one-third of patients with cancer develop symptoms of PTSD at some point in their treatment. However, few studies have evaluated the contributions of PTSD and sleep disturbance to pain processes in cancer populations. The current study used mediation models to test the hypothesis that sleep disturbance would mediate the relationships between PTSD symptoms and pain intensity and PTSD symptoms and pain interference in a sample of patients with cancer. Methods: A cross-sectional, retrospective chart review was conducted of the electronic medical records of 85 adult patients with cancer (89.4% female; 59% white; 42% metastatic) who sought individual psychosocial support services at our institution. Results: Post-traumatic stress disorder symptoms, sleep disturbance, pain intensity, and pain interference were all positively correlated (P < .01). Clinical levels of PTSD symptoms were reported by 30% to 60% of the sample. Even after controlling for metastatic disease, race, and cancer type, sleep disturbance mediated the relationships between PTSD symptoms and pain intensity (B ¼ 0.27; 95% CI: 0.10-0.44) and PTSD symptoms and pain-related interference (B ¼ 0.58; 95% CI: 0.28-0.87). Conclusions: The relationships among PTSD symptoms, pain intensity, and pain interference could be explained by co-occurring sleep disturbance. Given the high frequency of PTSD symptoms among patients with cancer and PTSD's known links to sleep problems and pain, clinicians should be attentive to the role that traumatogenic processes may play in eliciting sleep and pain-related complaints among patients with cancer.
Background
The diagnosis and treatment of cancer can be a psychologically traumatic experience for many patients, given that it is a lifethreatening illness and many of its treatments may involve significant violation of bodily integrity or also be considered life threatening (ie, surgery, immune-suppressing chemotherapy). In 2015, the National Cancer Institute (NCI) 1 reported that nearly one-third of patients with cancer develop symptoms of post-traumatic stress disorder (PTSD) during their treatment, including intrusive trauma-related thoughts, avoidance of trauma-related reminders, and hypervigilance and heightened arousal. 2 In addition to the emotional toll, cancer treatment and the disease itself may also be physically painful. 3 The American Cancer Society estimates that 80% of patients with advanced cancer experience moderate to severe pain. 4 Emotional distress and pain are comorbid in noncancer populations as well, and studies estimate that 20% to 70% of individuals with PTSD report pain-related complaints.
Sleep disturbance is a common factor of both PTSD 6 and pain conditions, 7 and there is increasing attention to this common complaint of patients with cancer. 8 In PTSD, sleep disturbances represent 2 diagnostic criteria of the disorder and include trouble falling and/or staying asleep and intrusive, distressing dreams. 2 Similarly, pain-related conditions and sleeping difficulties frequently co-occur. Although some studies have highlighted bidirectional pathways between sleep and pain, 9 longitudinal research in diverse chronic pain populations has implicated sleep disturbance as the probable driver of daily pain and pain-related dysfunction, and not vice versa. 7 Despite the increased awareness of PTSD-related concerns in patients with cancer and the documented incidence of cancer-related pain and sleep problems, the majority of studies that have examined the co-occurrence of PTSD, pain, and sleep problems have been conducted in veteran populations. [10] [11] [12] These studies with veterans have yielded results that are consistent with the results of Mystakidou and colleagues, 13 who found that, among a sample of patients with advanced stage cancer, poor sleep quality was linked with both increased pain and more severe symptoms of PTSD.
Although previous research has begun to assess the associations of sleep disturbance, PTSD, and pain among patients with cancer, additional investigation is warranted. In particular, determining the mechanisms of overlap among these variables may have implications for effective PTSD screening and treatment options for pain and sleep problems in patients with cancer as well as understanding the complex etiology of pain and pain interference (ie, pain that interferes with daily functioning) in cancer patient populations. In order to assess potential mediating pathways of pain, this study utilized mediation modeling (a statistical approach combining theory and data analysis) to ascertain whether the association of PTSD symptoms with pain intensity and pain interference could be explained or mediated by co-occurring sleep disturbance in a sample of patients with cancer. Given the lack of longitudinal data on pain and sleep problems in cancer patient populations, we generalized from the chronic pain literature to hypothesize that positive relationships among PTSD symptoms, pain intensity, and pain interference would be accounted for by co-occurring sleep disturbance.
Method

Participants and Procedure
This retrospective chart review study was approved by the institutional review board of our academic medical center. Because there was no face-to-face interaction with participants or storage of participant personal health information, this study was exempt from collecting informed consent. Records reviewed were from a convenience sample of 85 adult patients in active cancer treatment who self-referred for psychosocial support from a licensed clinical psychologist at our medical center's psychosocial oncology clinic between June 2014 and June 2015. From the larger pool of potential patient records to include from this time frame, children (18 and younger) and those who were not administered primary study measures (see below) were excluded.
Measures
Demographic and medical information. All diagnostic and demographic information (ie, age, gender, race/ethnicity, cancer type, metastatic status, receipt of chemotherapy, and radiation therapy) was obtained from review of participants' electronic medical records.
Post-traumatic stress disorder CheckList-Civilian version. Posttraumatic stress disorder symptoms were assessed with the PTSD CheckList-Civilian version (PCL-C), a 17-item measure that assesses the degree to which respondents have experienced symptoms of reexperiencing, avoidance/numbing, and hyperarousal symptoms associated with PTSD.
14 Respondents rate the extent to which they have been distressed by each symptom over the past month on a Likert-type scale from 1 (not at all) to 5 (extremely). Total scores range from 17 to 85, with higher scores indicating greater distress. Suggested cutoff scores of 30 and 45 denote clinical levels of PTSD symptomology in health maintenance organization samples and acute trauma populations, respectively. 15 Prior to analyses, the 2 sleep items from the PCL-C (having trouble falling/staying asleep and having distressing dreams) were subtracted from PCL-C total scores in order to prevent overlap with sleep items from the PatientReported Outcomes Measurement Information System 29 (PROMIS-29) measure. 16 Patient-Reported Outcomes Measurement Information System 29. Pain and sleep disturbance were assessed with the PROMIS-29, a 29-item inventory assessing distress and functionality over the previous 7 days across 7 domains including depression, anxiety, physical function, pain interference, fatigue, sleep disturbance, and social role activity/participation. 15 Sleep disturbance was assessed with the 4 sleep-related items from the PROMIS-29. Respondents were asked to provide an overall rating of their sleep quality (1 [very poor] to 5 [very good]) and rate the degree to which their sleep had been refreshing, if they had any problems with their sleep, or if they had any difficulty falling asleep (from 1 [not at all] to 5 [very much]). After reverse coding sleep quality ratings, total raw scores were calculated and converted into T-scores based on normed standard scores developed for the PROMIS-29 (with higher T-scores indicating greater sleep disturbance).
Pain interference was assessed with the 4 pain interference items from the PROMIS-29. Respondents were asked to rate the degree to which pain had interfered with their ability to complete day-to-day activities, work around the home, engage in social activities, and complete household chores (on a Likert-type scale from 1 [not at all] to 5 [very much]). Total raw scores were converted into T-scores based on normed standard scores developed for the PROMIS-29 (with higher T-scores indicating greater pain-related interference). The 1-item pain intensity question was interpreted as a raw score, based on PROMIS-29 scoring guidelines, and asked respondents to provide an average rating of pain on an 11-point Likert-type scale (0 [no pain] to 10 [worst imaginable pain]).
Data Analytic Strategy
Descriptive statistics and bivariate correlations were initially conducted to determine the strength and direction of relationships among primary study variables and covariates. Age, metastatic status, cancer type (ie, hematologic-based cancer vs solid tumor), chemotherapy, and radiation therapy were selected as covariates on the theoretical grounds that advanced age, disease severity, and active cancer treatment may impose a differential impact on sleep and pain outcomes.
Relationships among sleep disturbance, PTSD symptoms, pain intensity, and pain interference were then assessed with path analysis, a methodology that posits and statistically tests a theory-driven model. The path analyses were conducted with bootstrapped mediation models controlling for covariates of metastatic disease and African American race, which were indicated as significantly related to primary study variables at the zero-order level. 17 In brief, mediation testing and path analysis represent an empirical method that integrates theory and data analysis. Mediation is said to occur when the association between an independent variable (ie, PTSD) and dependent variable (ie, pain) is explained by an intervening or mediating third variable (ie, sleep disturbance). Whereas other analyses may adjust for potential confounders of a relationship to remove nuisance variation or noise, mediation is useful for considering whether a third variable or mediator may participate in a cascade of influence from one variable to the next. Beyond evaluating the hypothesized model that sleep disturbance would function as a mediator of the relationship between PTSD symptoms and pain intensity and the relationship between PTSD symptoms and pain interference, we also evaluated a plausible alternative model that linked sleep disturbance to pain intensity and pain interference via PTSD symptoms.
Results
Sample Characteristics
As noted in Table 1 , participants were predominantly female (89.3%) and approximately 52 years old (standard deviation [SD] ¼ 13). Most identified as white (58.8%), followed by black/African American (32.9%) and other (8.3%). Approximately 11% of the sample was diagnosed with hematologicbased cancer (eg, lymphoma, leukemia), and the most common solid tumor cancers were breast cancer (49.4%) and lung cancer (16.5%). Just under half (42.4%) of patients had metastatic disease. Nearly all patients were on chemotherapy (85.9%) and two-thirds were on concomitant radiation therapy (65.9%).
Based on PCL-C total scores (with sleep items included; M ¼ 38.06, SD ¼ 14.62), 64% of the sample endorsed clinical levels of PTSD symptoms (ie, clinical cutoff PCL-C total score of 30) and 34% fell above the clinical cutoff score of 45 for a probable PTSD diagnosis. 15 The average PCL-C score (without sleep items) was 35.31 (SD ¼ 13.99). The sample scored slightly above the general population on the PROMIS-29 sleep disturbance scale (T-score ¼ 54.30, standard error [SE] ¼ 3.40) and nearly 1 SD above the general population on the pain interference scale (T-score ¼ 58.50, SE ¼ 1.80). The average pain intensity rating was a 4.80 (SD ¼ 3.04), which is consistent with previously reported pain intensity ratings from patients in active cancer treatment. 18 As noted in Table 2 , bivariate correlations indicated that the PCL-C total score (without sleep items), sleep disturbance score, pain intensity score, and pain interference score were all positively related to each other (all P < .01).With regard to relationships between covariates and primary study variables, metastatic disease was negatively related to PCL-C total scores and African American race was positively related to pain intensity and pain interference scores (all P < .01). Accordingly, African American race and metastatic status were entered as dichotomous covariates in subsequent mediation models. In addition, although hematologic cancer status was not significantly related to primary study variables at the zero-order level, it was entered as a dichotomous covariate in order to control for differences in metastatic status between solid tumor cancers and hematologic cancers. Path analyses of our hypothesized models indicated that sleep disturbance scores mediated the association between PCL-C total scores (without sleep items) and pain intensity scores (R 2 ¼ .40) and the association between PCL-C total scores (without sleep items) and pain interference scores (R 2 ¼ .47; Figure 1 ). These effects were maintained even after controlling for metastatic disease, African American race, and hematologic cancer type. Of these covariates, only African American race remained significantly linked with pain intensity (B ¼ 2.08, SE ¼ .69) and pain interference (B ¼ 4.93, SE ¼ 1.23).
Evaluation of our alternative mediation model (Figure 2 ) indicated that PCL-C total score (without sleep items) was not Table 1 , PTSD symptoms were significantly correlated with pain intensity and pain interference at the zeroorder level (p < .05). However, after accounting for the effects of sleep disturbance, the relationship between PTSD symptoms and pain intensity and the relationship between PTSD symptoms and pain interference were no longer significant. Thus, sleep disturbance was a significant mediator of those relationships. Note. For clarity, pathways and values of covariates (i.e., metastatic status, African American race, and hematologic cancer type) not pictured. Table 1 , sleep disturbance was significantly correlated with pain intensity and pain interference at the zero-order level (p < .05). After accounting for the effects of PTSD symptoms, the significant relationship between sleep disturbance and pain intensity and the relationship between sleep disturbance and pain interference were still significant (p < .05). Thus, PTSD symptoms did not significantly mediate those relationships. Note. For clarity, pathways and values of covariates (i.e., metastatic status, African American race, and hematologic cancer type) not pictured. a significant mediator of the association between sleep disturbance scores and pain intensity scores or the association between sleep disturbance scores and pain interference scores.
Discussion
Approximately 30% to 60% of the current sample of patients with cancer reported clinical levels of PTSD symptoms, which is higher than the 2015 estimate by the NCI 1 and may be accounted for by the selection of patients receiving psychosocial oncology services. Pain and sleep-related complaints were also common in the current sample. Mediation analyses of our hypothesized and alternative models indicated that the relationships between PTSD symptoms, pain intensity, and pain interference could be explained in part by co-occurring sleep disturbance. One possibility is that intrusive trauma-related thoughts and memories may lead to presleep arousal, which may negatively impact overall sleep quality and duration. The degradation in sleep quality and duration may, in turn, deplete resources needed to effectively manage pain. Anxious and traumatized patients may also be more inclined to attend to and make catastrophic interpretations of physical ailments and pain and avoid activity that they believe will increase their anxiety and/or their pain. 19 These processes may then culminate in activity restriction and poorer overall quality of life.
Although prior studies have highlighted bidirectional pathways between sleep and pain 9 and sleep and PTSD, 20 our findings are consistent with past chronic pain research that posits sleep disturbance as the potential driver of daily pain and painrelated dysfunction. 7 To that end, the present findings are consistent with existing longitudinal models that link poor sleep to pain through cognitive, affective, and behavioral pathways. 21 Importantly, although our findings map on to the directional pathways between sleep disturbance and pain processes evinced in chronic pain populations, additional, longitudinal studies with cancer patient populations are needed to validate the directional pathways between sleep disturbance and pain reported here.
Of note, African American race and metastatic status were identified as key contributing factors to the relationships among PTSD symptoms, sleep disturbance, and pain. Participants who identified as African American had higher pain intensity and pain-related interference than participants from other racial backgrounds. These findings are consistent with documentation of worse self-reported pain outcomes among African Americans as compared to other racial groups 22 and warrant additional research on the mechanisms underlying these race-related differences in cancer patient populations. Although these patients were selected based on their engagement in psychosocial oncology services, racial and ethnic minorities and other marginalized groups may face barriers to accessing supportive oncology services.
In addition, metastatic status was found to be negatively related to PTSD symptoms, suggesting that, as compared to those with metastatic disease, individuals without metastatic disease experienced more severe symptoms of PTSD. Although this finding may appear counterintuitive, the literature regarding the relationship between disease staging and PTSD symptomology is decidedly mixed. Some studies have reported that PTSD may be more common among patients with cancer with later-stage disease versus earlier stages 23 ; however, the majority of studies that have examined disease stage in relation to PTSD are skewed toward earlier stage diseases. 24 Furthermore, many studies outright exclude patients with metastatic disease. [25] [26] [27] [28] [29] Thus, our finding contributes to the literature metastatic disease processes and PTSD symptoms and may indicate that patients with nonmetastatic disease are at a particularly high risk of experiencing severe symptoms of PTSD.
These results should be evaluated in the context of the current study's limitations. Data were cross-sectional; thus, our mediation models need validation in prospective, longitudinal study designs to determine whether sleep disturbance is a primary mechanism underlying the relationship between PTSD symptoms and pain in patients with cancer. In addition, the relationship between PTSD and depression is complex, with the 2 disorders so intertwined 30 that the Diagnostic and Statistical Manual of Mental Disorders, 5th Edition (DSM-5) has integrated symptoms of negative mood states (ie, anhedonia, negativistic thinking, and negative emotionality) into the new nosology. We acknowledge the considerable overlap between depression and PTSD and recognize that future studies would be needed to ascertain whether a preexisting or co-occurring diagnosis of depression alters the relationships reported here. Finally, data were collected via self-report from a small, mostly female, sample of patients in active cancer treatment who were receiving outpatient psychotherapy services. Although data may be of clinical relevance, they may not represent the diverse experiences of all patients with cancer.
This study offers additional support for the high frequency of PTSD symptoms, sleep problems, and pain-related complaints among patients with cancer. Furthermore, our study highlights important qualitative differences in PTSD symptomology based on metastatic disease status and the role of sleep disturbance as a mechanism linking PTSD symptoms to reports of pain. Currently, many psychosocial interventions for patients with cancer target individual symptom clusters (ie, pain or sleep disturbance). Appropriate screening for PTSD and traumarelated distress may aid in treatment planning to address multiple symptoms simultaneously in patients with cancer, particularly with regard to metastatic disease status. Thus, clinicians who provide psychosocial treatments to patients with cancer should be attentive to the role that traumatogenic processes may play in the context of sleep and pain-related complaints.
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